Member Article
Ascribe becomes EMIS Health
Bolton-based healthcare technology business Ascribe will from today be known as EMIS Health.
It follows a move by owner EMIS Group – the UK leader in connected healthcare software and services – to rebrand all of its healthcare software businesses under a single name.
From today, EMIS Health will become the unifying brand name for:
- EMIS – the UK market leader in primary care software and services (53% share of UK GP market) with a growing presence in community, child and mental health.
- Rx Systems – the single most widely used dispensary management system in community pharmacy (36% UK market share).
- Ascribe and Indigo 4 – providing a wide range of services across secondary care (systems used in 81% of NHS Acute Trusts).
- Digital Healthcare – the leading UK provider of software and services to support diabetic eye screening (81% English market share).
The move emphasises EMIS Health’s unique ability to join up healthcare technology and patient records across every major UK care setting – from high street pharmacies to GP surgeries, community services, A&E departments and specialist care.
Ascribe became part of EMIS Group in September 2013. In March 2015, Duane Lawrence – a respected IT executive with 25 years’ international experience – joined as Managing Director.
He said: “The change of name underlines the exciting opportunity that lies ahead of us – to join up our technologies and services to help the NHS to work more efficiently, and ultimately to deliver better patient care.”
EMIS Group Chief Executive Chris Spencer said: “The launch of EMIS Health signals a new era in the evolution of our healthcare software business.
“It follows extensive work behind the scenes to further integrate the different parts of the business and leverage their combined power to deliver truly joined-up patient care.
“Now is the time to signal our unique capability to customers, by uniting our expertise within different sectors under a single brand.”
This was posted in Bdaily's Members' News section by Simon Donohue .